Compounds > 1,4-phenylenebis(methylene)selenocyanate
Page last updated: 2024-11-05

1,4-phenylenebis(methylene)selenocyanate and Intraepithelial Prostatic Neoplasia

1,4-phenylenebis(methylene)selenocyanate has been researched along with Intraepithelial Prostatic Neoplasia in 1 studies

1,4-phenylenebis(methylene)selenocyanate: structure given in first source; inhibits DMBA-induced carcinogenesis by inhibiting DMBA-DNA adduct formation

Research Excerpts

ExcerptRelevanceReference
"The long latency of prostate cancer development provides an opportunity to intervene with agents of known mechanisms at various stages of disease progression."1.361,4-phenylenebis(methylene)selenocyanate, but not selenomethionine, inhibits androgen receptor and Akt signaling in human prostate cancer cells. ( El-Bayoumy, K; Facompre, ND; Pinto, JT; Sinha, R; Sun, YW, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Facompre, ND1
El-Bayoumy, K1
Sun, YW1
Pinto, JT1
Sinha, R1

Other Studies

1 other study available for 1,4-phenylenebis(methylene)selenocyanate and Intraepithelial Prostatic Neoplasia

ArticleYear
1,4-phenylenebis(methylene)selenocyanate, but not selenomethionine, inhibits androgen receptor and Akt signaling in human prostate cancer cells.
    Cancer prevention research (Philadelphia, Pa.), 2010, Volume: 3, Issue:8

    Topics: Androgen Antagonists; Antineoplastic Agents; Apoptosis; Cell Proliferation; Drug Evaluation, Preclin

2010